Chemomab Therapeutics Ltd.
Related Filers (42)
- Cohen Neil Harris (10)
- Access Industries Holdings LLC (7)
- OrbiMed Israel BioFund GP Limited Partnership (6)
- Darvish Nissim (6)
- Maryles Joel Michael (5)
- Mor George Adi (5)
- Clal Biotechnology Industries Ltd. (4)
- Palisade Medical Equity I, LP (4)
- Moses Alan Charles (4)
- Nicaise Claude (4)
- Fatal Sigal (4)
- MEITAV DASH INVESTMENTS LTD (3)
- Gabriel Capital Management Ltd. (3)
- THIEL PETER (3)
- Marvin Donald (3)
- OrbiMed Israel GP Ltd. (3)
- Quigley Jill M. (3)
- Polovets Stanislav (2)
- SQUINTO STEPHEN P (2)
- Pfost Dale R (2)
- BIOCANCELL THERAPEUTICS INC. (1)
- Daly Sean T (1)
- ACCESS INDUSTRIES MANAGEMENT, LLC (1)
- Gilon Ohev-Zion Michal (1)
- Makov Efrat (1)
- Blavatnik Len (1)
- Kerstein David (1)
- Haluska Frank (1)
- Roshan Salar (1)
- Alon Ruth (1)
- Gonen Ofer (1)
- Kohlberg Isaac T. (1)
- ACCESS INDUSTRIES, LLC (1)
- Knickerbocker Ron (1)
- HARDY REGINALD L (1)
- HOWARD LAWRENCE (1)
- Burgin Jonathan (1)
- VERU DENNISON T (1)
- DiPalma Stephen J. (1)
- Fine Andrew (1)
- Aharon Arnon (1)
- Frankel Matthew Bejosa (1)
- Show More ...
Financials (14)
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Monday, 3/20/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/10/2022
Quarterly Report for period ending 2022-09-30
10-Q
Friday, 8/12/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Wednesday, 3/30/2022
Annual Report for period ending 2021-12-31
10-Q
Friday, 11/12/2021
Quarterly Report for period ending 2021-09-30
10-Q
Friday, 8/13/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K
Tuesday, 3/9/2021
Annual Report for period ending 2020-12-31
10-Q
Monday, 11/16/2020
Quarterly Report for period ending 2020-09-30
10-Q
Friday, 8/14/2020
Quarterly Report for period ending 2020-06-30
10-Q
Thursday, 5/7/2020
Quarterly Report for period ending 2020-03-31
10-K
Tuesday, 3/17/2020
Annual Report for period ending 2019-12-31
News (50)
8-K
Friday, 6/16/2023
Current report filing
8-K
Monday, 6/5/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Tuesday, 2/21/2023
Current report filing
8-K
Tuesday, 2/21/2023
Current report filing
8-K
Wednesday, 1/11/2023
Current report filing
8-K
Tuesday, 1/3/2023
Current report filing
8-K/A
Tuesday, 11/29/2022
Current report filing
8-K
Wednesday, 11/16/2022
Current report filing
8-K
Monday, 11/14/2022
Current report filing
8-K
Friday, 8/12/2022
Current report filing
8-K
Tuesday, 6/21/2022
Current report filing
8-K
Wednesday, 6/8/2022
Current report filing
8-K
Wednesday, 6/1/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Wednesday, 3/9/2022
Current report filing
8-K
Friday, 2/11/2022
Current report filing
8-K
Thursday, 12/16/2021
Current report filing
8-K
Friday, 12/3/2021
Current report filing
8-K/A
Friday, 11/12/2021
Current report filing
8-K
Friday, 11/12/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Monday, 11/8/2021
Current report filing
8-K
Wednesday, 11/3/2021
Current report filing
8-K
Tuesday, 10/26/2021
Current report filing
8-K
Monday, 10/25/2021
Current report filing
8-K
Thursday, 9/2/2021
Current report filing
8-K
Friday, 8/13/2021
Current report filing
8-K
Thursday, 7/22/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K/A
Wednesday, 4/14/2021
Current report filing
8-K
Monday, 4/5/2021
Current report filing
8-K/A
Friday, 3/19/2021
Current report filing
8-K
Wednesday, 3/17/2021
Current report filing
8-K
Wednesday, 3/10/2021
Current report filing
8-K
Monday, 2/8/2021
Current report filing
8-K
Tuesday, 12/15/2020
Current report filing
8-K
Tuesday, 10/20/2020
Current report filing
8-K
Wednesday, 7/15/2020
Current report filing
8-K
Thursday, 7/9/2020
Current report filing
8-K
Thursday, 5/21/2020
Current report filing
8-K
Wednesday, 5/6/2020
Current report filing
8-K
Friday, 4/24/2020
Current report filing
8-K
Wednesday, 4/15/2020
Current report filing
8-K
Monday, 3/16/2020
Current report filing
8-K
Monday, 2/10/2020
Current report filing
8-K
Tuesday, 2/4/2020
Current report filing
8-K
Friday, 1/31/2020
Current report filing
8-K
Friday, 1/10/2020
Current report filing
8-K
Thursday, 1/2/2020
Current report filing
Other (71)
6-K
Wednesday, 1/3/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/9/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Friday, 11/3/2023
Notice of Effectiveness
CORRESP
Wednesday, 11/1/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Monday, 10/30/2023
Registration statement for specified transactions by certain foreign private issuers
F-3
Monday, 10/16/2023
Registration statement for specified transactions by certain foreign private issuers
6-K
Monday, 8/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
ARS
Tuesday, 3/21/2023
Annual report to security holders
EFFECT
Monday, 5/17/2021
Notice of Effectiveness
CORRESP
Wednesday, 5/12/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 4/28/2021
Notice of Effectiveness
CORRESP
Monday, 4/26/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Tuesday, 3/30/2021
Exempt (Private) Offering
CORRESP
Wednesday, 2/10/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 2/10/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 2/10/2021
Notice of Effectiveness
CORRESP
Monday, 4/6/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Thursday, 11/21/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 11/15/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/12/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/23/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/13/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/6/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/8/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/18/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/28/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/22/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F/A
Wednesday, 4/24/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
20-F
Monday, 3/25/2019
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/14/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/12/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/14/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CT ORDER
Tuesday, 2/12/2019
Order Granting Confidential Treatment
6-K
Tuesday, 2/12/2019
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Monday, 2/11/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Monday, 2/11/2019
Registration statement for securities of certain foreign private issuers
CERT
Monday, 2/11/2019
Certification by an exchange approving securities for listing
EFFECT
Monday, 2/11/2019
Notice of Effectiveness
8-A12B
Friday, 2/8/2019
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
F-1/A
Friday, 2/8/2019
Registration statement for securities of certain foreign private issuers
CORRESP
Thursday, 2/7/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 2/7/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 2/7/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1/A
Tuesday, 2/5/2019
Registration statement for securities of certain foreign private issuers
F-1/A
Thursday, 1/31/2019
Registration statement for securities of certain foreign private issuers
CORRESP
Monday, 1/7/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-1
Monday, 1/7/2019
Registration statement for securities of certain foreign private issuers
20-F
Tuesday, 4/23/2013
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
15-15D
Wednesday, 1/2/2013
Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act
6-K
Wednesday, 12/26/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 12/18/2012
Notice of Effectiveness
POS AM
Monday, 12/17/2012
Post-effective amendment to a registration statement that is not immediately effective upon filing
6-K
Monday, 12/17/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/27/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/14/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/5/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/22/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 10/2/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/1/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/4/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/20/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/13/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/9/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/23/2012
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Thursday, 6/7/2012
Notice of Effectiveness
F-4/A
Tuesday, 6/5/2012
Registration statement for securities issued by foreign private issuers in certain business combination transactions
F-4/A
Tuesday, 5/29/2012
Registration statement for securities issued by foreign private issuers in certain business combination transactions
F-4
Tuesday, 1/24/2012
Registration statement for securities issued by foreign private issuers in certain business combination transactions
Ownership (96)
SC 13D/A
Wednesday, 11/15/2023
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
4
Wednesday, 7/5/2023
Darvish Nissim: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Quigley Jill M.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Fatal Sigal: Statement of changes in beneficial ownership of securities
3
Monday, 6/5/2023
Fatal Sigal: Initial statement of beneficial ownership of securities
4
Thursday, 3/23/2023
Darvish Nissim: Statement of changes in beneficial ownership of securities
4
Thursday, 3/23/2023
Moses Alan Charles: Statement of changes in beneficial ownership of securities
4
Thursday, 3/23/2023
Nicaise Claude: Statement of changes in beneficial ownership of securities
4
Thursday, 3/23/2023
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
OrbiMed Israel GP Ltd.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
Mor George Adi: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/5/2023
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
4
Friday, 11/18/2022
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 11/17/2022
Mor George Adi: Major Shareholders
4
Thursday, 11/17/2022
Mor George Adi: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/15/2022
Frankel Matthew Bejosa: Initial statement of beneficial ownership of securities
4
Tuesday, 6/21/2022
Marvin Donald: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/21/2022
Quigley Jill M.: Initial statement of beneficial ownership of securities
4
Wednesday, 5/25/2022
Maryles Joel Michael: Statement of changes in beneficial ownership of securities
4
Thursday, 5/19/2022
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
4
Monday, 3/21/2022
Marvin Donald: Statement of changes in beneficial ownership of securities
4
Monday, 3/21/2022
Maryles Joel Michael: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/15/2022
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/15/2022
Pfost Dale R: Statement of changes in beneficial ownership of securities
4
Monday, 3/14/2022
Darvish Nissim: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/9/2022
Darvish Nissim: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/9/2022
Maryles Joel Michael: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/9/2022
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/9/2022
Nicaise Claude: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/9/2022
Moses Alan Charles: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/10/2022
Gabriel Capital Management Ltd.: Major Shareholders
SC 13D
Thursday, 1/20/2022
Mor George Adi: Major Shareholders
4
Wednesday, 12/8/2021
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
3
Friday, 11/12/2021
Marvin Donald: Initial statement of beneficial ownership of securities
3
Thursday, 11/4/2021
Pfost Dale R: Initial statement of beneficial ownership of securities
4
Monday, 5/10/2021
Fatal Sigal: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
Moses Alan Charles: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
Darvish Nissim: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
Maryles Joel Michael: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
SQUINTO STEPHEN P: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/21/2021
Nicaise Claude: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 4/15/2021
Access Industries Holdings LLC: Major Shareholders
3
Friday, 3/26/2021
OrbiMed Israel GP Ltd.: Initial statement of beneficial ownership of securities
SC 13G
Friday, 3/26/2021
THIEL PETER: Major Shareholders
4
Friday, 3/26/2021
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 3/26/2021
OrbiMed Israel BioFund GP Limited Partnership: Major Shareholders
3
Thursday, 3/25/2021
Darvish Nissim: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Maryles Joel Michael: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Aharon Arnon: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Moses Alan Charles: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
SQUINTO STEPHEN P: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Mor George Adi: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Nicaise Claude: Initial statement of beneficial ownership of securities
3
Thursday, 3/25/2021
Fatal Sigal: Initial statement of beneficial ownership of securities
4
Thursday, 3/18/2021
THIEL PETER: Statement of changes in beneficial ownership of securities
3
Thursday, 3/18/2021
THIEL PETER: Initial statement of beneficial ownership of securities
4
Thursday, 3/18/2021
OrbiMed Israel GP Ltd.: Statement of changes in beneficial ownership of securities
3
Friday, 3/12/2021
Polovets Stanislav: Initial statement of beneficial ownership of securities
4
Friday, 3/12/2021
Polovets Stanislav: Statement of changes in beneficial ownership of securities
3
Thursday, 3/11/2021
Cohen Neil Harris: Initial statement of beneficial ownership of securities
3
Thursday, 3/11/2021
Fine Andrew: Initial statement of beneficial ownership of securities
4
Thursday, 3/11/2021
Cohen Neil Harris: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 12/21/2020
Access Industries Holdings LLC: Major Shareholders
SC 13D/A
Friday, 12/18/2020
Palisade Medical Equity I, LP: Major Shareholders
SC 13D/A
Friday, 5/22/2020
Palisade Medical Equity I, LP: Major Shareholders
3
Thursday, 5/7/2020
DiPalma Stephen J.: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 3/31/2020
Access Industries Holdings LLC: Major Shareholders
SC 13D/A
Monday, 1/13/2020
Access Industries Holdings LLC: Major Shareholders
3
Thursday, 1/2/2020
Daly Sean T: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Haluska Frank: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Gonen Ofer: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
HOWARD LAWRENCE: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Alon Ruth: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Makov Efrat: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Knickerbocker Ron: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Kohlberg Isaac T.: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Roshan Salar: Initial statement of beneficial ownership of securities
SC 13G
Thursday, 1/2/2020
Gabriel Capital Management Ltd.: Major Shareholders
3
Thursday, 1/2/2020
HARDY REGINALD L: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Gilon Ohev-Zion Michal: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Burgin Jonathan: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
VERU DENNISON T: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Kerstein David: Initial statement of beneficial ownership of securities
3
Thursday, 1/2/2020
Blavatnik Len: Initial statement of beneficial ownership of securities
SC 13D/A
Tuesday, 12/31/2019
Access Industries Holdings LLC: Major Shareholders
3
Tuesday, 12/31/2019
Gabriel Capital Management Ltd.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 11/18/2019
MEITAV DASH INVESTMENTS LTD: Major Shareholders
SC 13D/A
Thursday, 6/27/2019
Palisade Medical Equity I, LP: Major Shareholders
SC 13G/A
Wednesday, 6/26/2019
MEITAV DASH INVESTMENTS LTD: Major Shareholders
SC 13G
Tuesday, 6/11/2019
MEITAV DASH INVESTMENTS LTD: Major Shareholders
SC 13D/A
Monday, 2/25/2019
Palisade Medical Equity I, LP: Major Shareholders
SC 13D
Thursday, 2/21/2019
Access Industries Holdings LLC: Major Shareholders
SC 13D/A
Tuesday, 1/8/2013
Clal Biotechnology Industries Ltd.: Major Shareholders
SC 13D/A
Monday, 12/17/2012
Clal Biotechnology Industries Ltd.: Major Shareholders
SC 13D
Thursday, 8/16/2012
Clal Biotechnology Industries Ltd.: Major Shareholders
Prospectus (34)
RW
Friday, 6/2/2023
Registration Withdrawal Request
S-1/A
Friday, 5/19/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 3/22/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 3/21/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 2/22/2023
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Tuesday, 2/21/2023
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 1/13/2023
General form of registration statement for all companies including face-amount certificate companies
S-8
Monday, 8/15/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 4/25/2022
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Monday, 9/13/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3
Friday, 4/30/2021
Registration statement for specified transactions by certain issuers
424B3
Thursday, 4/29/2021
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Thursday, 4/15/2021
Registration statement for specified transactions by certain issuers
425
Wednesday, 3/10/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 3/9/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
424B3
Friday, 2/12/2021
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Wednesday, 2/10/2021
Registration of securities issued in business combination transactions
425
Monday, 2/8/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 2/2/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-4
Wednesday, 1/13/2021
Registration of securities issued in business combination transactions
425
Monday, 1/11/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Tuesday, 1/5/2021
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
S-8
Tuesday, 3/17/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Monday, 7/22/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Wednesday, 2/13/2019
Prospectus filed pursuant to Rule 424(b)(4)
DRS/A
Tuesday, 11/27/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Monday, 11/26/2018
Correspondence Related to Draft Registration Statement
DRS
Friday, 9/28/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Tuesday, 11/3/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Tuesday, 9/22/2015
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
S-8 POS
Thursday, 12/27/2012
Post-effective amendment to a S-8 registration statement
S-8
Wednesday, 8/15/2012
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Thursday, 6/7/2012
Prospectus filed pursuant to Rule 424(b)(3)
425
Monday, 11/7/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Proxies (12)
DEFA14A
Tuesday, 5/31/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Thursday, 4/28/2022
Definitive proxy statements
DEF 14A
Wednesday, 1/5/2022
Definitive proxy statements
PRE 14A
Thursday, 12/23/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Friday, 9/17/2021
Definitive proxy statements
PRE 14A
Friday, 9/3/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Monday, 6/14/2021
Definitive proxy statements
PRE 14A
Tuesday, 6/1/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Tuesday, 12/15/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Friday, 4/17/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/6/2020
Definitive proxy statements
PRE 14A
Monday, 3/30/2020
Preliminary proxy statement not related to a contested matter or merger/acquisition